{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-08-21",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 6
    }
  },
  "results": [
    {
      "product_ndc": "0002-4794",
      "generic_name": "orforglipron",
      "labeler_name": "Eli Lilly and Company",
      "brand_name": "FOUNDAYO",
      "active_ingredients": [
        {
          "name": "ORFORGLIPRON CALCIUM",
          "strength": "5.5 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0002-4794-31",
          "description": "1 BOTTLE in 1 CARTON (0002-4794-31)  / 30 TABLET, FILM COATED in 1 BOTTLE (0002-4794-01)",
          "marketing_start_date": "20260401",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Eli Lilly and Company"
        ],
        "rxcui": [
          "2739844",
          "2739850",
          "2739852",
          "2739854",
          "2739856",
          "2739858",
          "2739860",
          "2739862",
          "2739864",
          "2739866",
          "2739868",
          "2739870"
        ],
        "spl_set_id": [
          "8ac446c5-feba-474f-a103-23facb9b5c62"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "VI5M9OZV2X"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "TABLET, FILM COATED",
      "spl_id": "ebe44919-a00d-4ea1-a511-18e6a87da34c",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20260401",
      "product_id": "0002-4794_ebe44919-a00d-4ea1-a511-18e6a87da34c",
      "application_number": "NDA220934",
      "brand_name_base": "FOUNDAYO",
      "pharm_class": [
        "Decreased Gastric Motility [PE]",
        "GLP-1 Receptor Agonist [EPC]",
        "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]",
        "Increased Gastric Muscle Tone [PE]"
      ]
    }
  ]
}